Comments
Loading...

Allogene Therapeutics

ALLONASDAQ
Logo brought to you by Benzinga Data
$2.27
-0.19-7.72%
At close: -
$2.31
0.041.77%
After Hours: Nov 15, 5:57 PM EDT

Allogene Therapeutics (NASDAQ:ALLO) Stock Quotes, Forecast and News Summary

Allogene Therapeutics Stock (NASDAQ: ALLO) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
2
May
5
Aug
1
Oct
2
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$2.52
Close$2.27
Volume / Avg.3.09M / 2.01M
Day Range$2.26 - $2.52
52 Wk Range2.01 - 5.78
Market Cap$484.36M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
36
Short Interest
24.84%
Days to Cover18.96

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ALLO
KALV

FAQ

Q

How do I buy Allogene Therapeutics (ALLO) stock?

A

You can purchase shares of Allogene Therapeutics (NASDAQ:ALLO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Allogene Therapeutics (ALLO) competitors?

Q

What is the forecast, or price target, for Allogene Therapeutics (ALLO) stock?

A

Allogene Therapeutics has a consensus price target of $13.31.

Q

What is the current price for Allogene Therapeutics (ALLO)?

A

The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $2.3101 last updated November 15, 2024 at 5:57 PM EST.

Q

Does Allogene Therapeutics (ALLO) pay a dividend?

A

There are no upcoming dividends for Allogene Therapeutics.

Q

When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?

A

Allogene Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Q

Is Allogene Therapeutics (ALLO) going to split?

A

There is no upcoming split for Allogene Therapeutics.

Q

What sector and industry does Allogene Therapeutics (ALLO) operate in?

A

Allogene Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch